Qi Y - Search Results

1

Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO/NCCES01 trial.

Qin J, Xue L, Hao A, Guo X, Jiang T, Ni Y, Liu S, Chen Y, Jiang H, Zhang C, Kang M, Lin J, Li H, Li C, Tian H, Li L, Fu J, Zhang Y, Ma J, Wang X, Fu M, Yang H, Yang Z, Han Y, Chen L, Tan L, Dai T, Liao Y, Zhang W, Li B, Chen Q, Guo S, Qi Y, Wei L, Li Z, Tian Z, Kang X, Zhang R, Li Y, Wang Z, Chen X, Hou Z, Zheng R, Zhu W, He J, Li Y. Qin J, et al. Among authors: qi y. Nat Med. 2024 Sep;30(9):2549-2557. doi: 10.1038/s41591-024-03064-w. Epub 2024 Jul 2. Nat Med. 2024. PMID: 38956195 Free PMC article. Clinical Trial.

2

Development and Validation of a Deep Learning Radiomics Model to Predict High-Risk Pathologic Pulmonary Nodules Using Preoperative Computed Tomography.

Ye G, Wu G, Li K, Zhang C, Zhuang Y, Liu H, Song E, Qi Y, Li Y, Yang F, Liao Y. Ye G, et al. Among authors: qi y. Acad Radiol. 2024 Apr;31(4):1686-1697. doi: 10.1016/j.acra.2023.08.040. Epub 2023 Oct 5. Acad Radiol. 2024. PMID: 37802672

3

CT-based quantification of intratumoral heterogeneity for predicting pathologic complete response to neoadjuvant immunochemotherapy in non-small cell lung cancer.

Ye G, Wu G, Zhang C, Wang M, Liu H, Song E, Zhuang Y, Li K, Qi Y, Liao Y. Ye G, et al. Among authors: qi y. Front Immunol. 2024 Jun 12;15:1414954. doi: 10.3389/fimmu.2024.1414954. eCollection 2024. Front Immunol. 2024. PMID: 38933281 Free PMC article.

4

Non-invasive multimodal CT deep learning biomarker to predict pathological complete response of non-small cell lung cancer following neoadjuvant immunochemotherapy: a multicenter study.

Ye G, Wu G, Qi Y, Li K, Wang M, Zhang C, Li F, Wee L, Dekker A, Han C, Liu Z, Liao Y, Shi Z. Ye G, et al. Among authors: qi y. J Immunother Cancer. 2024 Sep 3;12(9):e009348. doi: 10.1136/jitc-2024-009348. J Immunother Cancer. 2024. PMID: 39231545 Free PMC article.

5

Neoadjuvant camrelizumab followed by concurrent camrelizumab plus chemotherapy for locally advanced esophageal squamous cell carcinoma: a single-arm, phase II study.

Sheng Y, Meng X, Zhang C, Shan Z, Li F, Wu B, Xu M, Li A, Guan L, Chen L, Sun S, Ma Y, Lu T, Zhao S, Fan Q, Qi Y, Wang F. Sheng Y, et al. Among authors: qi y. J Thorac Dis. 2024 Aug 31;16(8):5337-5347. doi: 10.21037/jtd-24-1141. Epub 2024 Aug 28. J Thorac Dis. 2024. PMID: 39268120 Free PMC article.

6

Integrative analyses of bulk and single-cell RNA-seq reveals the correlation between SPP1⁺ macrophages and resistance to neoadjuvant chemoimmunotherapy in esophageal squamous cell carcinoma.

Geng Z, Li F, Yang Z, Li B, Xu Y, Wu B, Sheng Y, Yuan P, Huang L, Qi Y. Geng Z, et al. Among authors: qi y. Cancer Immunol Immunother. 2024 Oct 5;73(12):257. doi: 10.1007/s00262-024-03848-6. Cancer Immunol Immunother. 2024. PMID: 39367943 Free PMC article.

7

A ¹⁸F-FDG PET/CT-based deep learning-radiomics-clinical model for prediction of cervical lymph node metastasis in esophageal squamous cell carcinoma.

Yuan P, Huang ZH, Yang YH, Bao FC, Sun K, Chao FF, Liu TT, Zhang JJ, Xu JM, Li XN, Li F, Ma T, Li H, Li ZH, Zhang SF, Hu J, Qi Y. Yuan P, et al. Among authors: qi y. Cancer Imaging. 2024 Nov 12;24(1):153. doi: 10.1186/s40644-024-00799-0. Cancer Imaging. 2024. PMID: 39533388 Free PMC article.

8

HDAC inhibitor trichostatin A suppresses esophageal squamous cell carcinoma metastasis through HADC2 reduced MMP-2/9.

Wang F, Qi Y, Li X, He W, Fan QX, Zong H. Wang F, et al. Among authors: qi y. Clin Invest Med. 2013 Apr 1;36(2):E87-94. doi: 10.25011/cim.v36i2.19571. Clin Invest Med. 2013. PMID: 23544610

9

Proteasome inhibitor MG132 inhibits the proliferation and promotes the cisplatin-induced apoptosis of human esophageal squamous cell carcinoma cells.

Dang L, Wen F, Yang Y, Liu D, Wu K, Qi Y, Li X, Zhao J, Zhu D, Zhang C, Zhao S. Dang L, et al. Among authors: qi y. Int J Mol Med. 2014 May;33(5):1083-8. doi: 10.3892/ijmm.2014.1678. Epub 2014 Feb 27. Int J Mol Med. 2014. PMID: 24584782 Free PMC article.

10

High expression of MAGE-A9 is associated with unfavorable survival in esophageal squamous cell carcinoma.

Qi Y, Cao KX, Xing FC, Zhang CY, Huang Q, Wu K, Wen FB, Zhao S, Li X. Qi Y, et al. Oncol Lett. 2017 Sep;14(3):3415-3420. doi: 10.3892/ol.2017.6614. Epub 2017 Jul 20. Oncol Lett. 2017. PMID: 28927095 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,157 results

Search Page

Filters